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Objective: This study was conducted to compare epinephrine and salbutamol nebulization in emergency management of 
moderately ill children less than one and a half years old with bronchiolitis in terms of mean change in respiratory distress 
assessment instrument (RDAI) score. 
Materials and Methods: Randomized controlled design was selected in this trial at the Department of Pediatrics, KRL 
Hospital Islamabad, Pakistan from 24th April 2016 to 24th October 2016. Sixty children with acute bronchiolitis, having a 
moderate degree of illness (RDAI 8-15) were included in this study. Patient were randomly allocated into Group A 
(epinephrine = 0.1 mL/kg in concentration of 1:10000) and Group B (salbutamol = 0.15 mg/kg combined with 3 mL 0.9% 
normal saline). It was delivered by a nebulizer and a face mask with a continuous flow of 6 L/min at100% oxygen. Data was 
collected on a predesigned performa and assessed with reference to mean change in RDAI score.  
Results: The patients ' mean age in Group A and Group B were 10.57±4.22 and 11.63±3.14 months, respectively. The majority 
of the patients were males (56%). The mean RDAI score was insignificant between the two groups, both at baseline 
(11.57±2.21 in epinephrine group vs 11.3±2.14 in salbutamol group, p = 0.63) and 125 minutes (4.77±2.19 in Epinephrine group 
vs 5.43±1.69 in Salbutamol group, p = 0.19). However, when stratified according to age and gender, the mean RDAI score was 
found statistically significant among the 2-12 months age group (p = 0.0045) and female gender (p = 0.0052). 
Conclusion: Epinephrine and salbutamol have similar effects in acute bronchiolitis when compared with regards to mean 
change in RDAI score.  
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Introduction 
 
Acute bronchiolitis is a viral disease with Respiratory 
syncytial virus (RSV) as the main cause in more than 
half of the cases. Approximately 75,000-125,000 
children aged less than 1 year old are hospitalized 
annually in the United States due to RSV infection.1 
RSV is the main viral disease-causing mortality in 
infants.2 In Pakistan, a winter spike of this virus was 
noted. There is an increase of 30-50% in the positivity 
of RSV cases from December to February in Pakistan.3 
A meta-analysis showed that Beta 2-agonist therapy 
does not improve saturation of oxygen, does not lessen 
hospital stay, does not help in reducing hospitalization 
rate but can result in increased respiratory rate.4 A trial 
conducted by Farooq A et al.5 in Islamabad showed 
that epinephrine could be a more effective treatment 
than salbutamol in the emergency management of 
acute bronchiolitis (mean RDAI score after 48 hours in 
the epinephrine group was 8.35±1.36 as compared to 
10.07±1.37 in the salbutamol group). Another meta-
analysis also showed the effectiveness and superiority 
of adrenaline over salbutamol. It was also helpful in 
reducing respiratory rate.6 However, other studies did 
not reveal any significant difference between 
salbutamol and epinephrine in terms of symptomatic 
improvement.7 So, the optimal treatment of 
bronchiolitis remains unclear. Additionally, there is a 
limited local study available. 
The rationale of this study was to compare the two 
drugs in the emergency treatment of acute 
bronchiolitis. The results of this study will help to 
choose the appropriate drug in reducing symptoms of 
the disease and will also provide the local data 
regarding its management. 
 
Materials and Methods 
 
A randomized controlled trial was conducted in the 
Paediatrics department of KRL Hospital, Islamabad 
from 24th April 2016 to 24th October 2016, after taking 
approval from the Institutional Research Forum of the 
hospital. 
60 patients, who fulfilled the inclusion criteria, were 
enrolled in the study. All patients with a diagnosis of 
acute bronchiolitis, between ages 2-18 months of both 
genders, and a moderate degree of illness (RDAI score 
= 8-15) were included in the study. RDAI scoring was 
done clinically based on wheezing (total score 8) and 
retractions (total score 9) and patients have scored 0 to 
17 accordingly.8 Patients with a family history of 
asthma, previous use of bronchodilators, requiring 
influenza vaccine prophylaxis and RDAI score > 15 
were excluded.  
A “written informed consent” was taken from the 
parents of the patients. The double-blinded 
randomized selection was done to eliminate any sort 
of bias during the study. Patients were assigned into 
two groups (30 patients each) by giving them random 
numbers generated by a pharmacist. Group A received 
a dose of epinephrine nebulization (0.1mL/kg in the 
concentration of 1:10000) and Group B received 
salbutamol nebulization (0.15 mg/kg) with 3 mL of 
0.9% isotonic saline solution and delivered to the 
patient by the nebulizer and a face mask with a 
continuous flow of oxygen. 
Infants were monitored by weight, respiratory rate, 
SpO2 (determined by pulse oximeter), and heart rate. 
The study drug was administered at 0, 25, and 50 
minutes. The infant’s condition was assessed by an 
independent investigator before giving each drug at 
75, 100, and 125 minutes. The duration of patient 
retention in the emergency department was at least 
125 minutes. At the end of this duration, RDAI score, 
respiratory rate, SpO2, heart rate, and the need for 
hospital admission based on the patient’s clinical 
assessment was recorded on a preformed performa. 
SPSS v17.0 was used for data analysis. Frequencies 
and percentages were calculated for qualitative 
variables. The quantitative variables were assessed at 
baseline and 125 minutes and mean change in RDAI 
score were presented as mean and standard deviation. 
The modifiers like age and gender were controlled by 
stratification. Post-stratification independent sample 
T-test was applied to compare mean change in RDAI 





Out of the 60 patients included in the study, 60% of 
patients in Group A and 53.3% in Group B were males 
whereas 40% in Group A and 46.7% in Group B were 
females. The mean age of the patients in both groups 
was presented in Table 1. 
The mean weight of the patients was 13.54±3.61 kg in 
the epinephrine group while 14.77±4.14 kg in the 
salbutamol group. The mean RDAI score at baseline 
was 11.57±2.21 in Group A and 11.3±2.14 in Group B 
(p = 0.63). After 125 minutes, the mean RDAI score 
was 4.77±2.19 in the epinephrine group compared to 
5.43±1.69 in the salbutamol Group (p= 0.19, Table 2). 
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Stratification according to mean RDAI score with 
respect to age and gender was presented in Table 3. 
 





(n = 30) 
Salbutamol 
Group 
(n = 30) 
2-12 months 19 63.33% 21 70% 
13-18 months 11 36.67% 09 30% 
Total 30 100% 30 100% 
Mean ± SD 10.57 ± 4.22 11.63 ± 3.14 
 
Table 2: Mean RDAI score at baseline and at 125 
minutes in both groups 
Variable Treatment groups P-
value Epinephrine 
Group 
(n = 30) 
Salbutamol 
Group 
(n = 30) 









4.77 2.19 5.43 1.69 0.1964 
 
Table 3: Treatment efficacy in terms of mean RDAI 
score stratified for Age & Gender in both groups 
Variable Treatment groups P-
value Epinephrine 
Group 
(n = 30) 
Salbutamol 
Group 






4.42 2.09 5.81 1.50 0.0045 
13-18 
months 
5.36 2.34 4.56 1.88 0.1497 
Gen
der 
Male 4.92 2.15 4.71 1.86 0.6873 




Acute bronchiolitis is a viral disease predominantly 
with RSV-responsible organisms in the majority of 
cases. In our study, most of the infants belonged to the 
2-12 months age group as compared to the 13-18 
months group (66.6% vs 33.4%). The mean RDAI score 
at baseline and 125 minutes were statistically 
insignificant between the two groups. (p = 0.63 vs p = 
0.19 respectively) 
A recent study by Usman S et al.9 in Lahore showed 
that epinephrine use over salbutamol could be more 
effective in the emergency treatment of the illness 
(Mean RDAI score at 48 hours was 1.6±1.6 in the 
epinephrine group vs 2.4±2 in the salbutamol group). 
This is in concert with the findings of our study. 
However, the results were statistically insignificant. 
This study also found a reduction in the duration of 
hospital stay of those treated with epinephrine. 
Another meta-analysis showed the effectiveness and 
superiority of epinephrine among outpatients in terms 
of improvement in respiratory rate and RDAI score 
with age variance.6 
Nada et al10 conducted a study in Iraq to investigate 
the effect of epinephrine and salbutamol in the 
treatment of acute bronchiolitis in infants. In their 
findings, the mean SpO2 was significantly on a higher 
side in the epinephrine group (p=0.008) and there was 
also improvement in respiratory rate (p=0.003). It was 
concluded that epinephrine has more efficacy in 
comparison to salbutamol in patients admitted with 
bronchiolitis. 
There is substantial variation seen regarding the 
management of infants with bronchiolitis between 
countries. Various meta-analyses did not find 
bronchodilators including epinephrine and salbutamol 
effective in treating patients with bronchiolitis, even 
antibiotics and steroids were equally found ineffective 
in its management.11 A randomized double-blind trial 
from Turkey showed no statistical difference between 
nebulized epinephrine and salbutamol in terms of 
discharge rate at 24 hours, however adrenaline with 
3% hypertonic helped reduce the length of stay 
(p=0.039).12 Racemic epinephrine was compared with 
hypertonic saline in terms of length of stay by Yasin F 
et al13 and found epinephrine effective in reducing the 
length of stay in patients with moderate bronchiolitis. 
However, some contrasting results were also in 
literature, where researchers demonstrated equal 
effectiveness of salbutamol and epinephrine.14   
The main limitation of our study was the small sample 
size in both groups of children. It is recommended that 
further studies should be done on a larger number of 
patients and at a more comprehensive level to observe 
the efficacy of epinephrine over salbutamol and to 
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Conclusion 
  
Epinephrine and salbutamol nebulization have similar 
effects in acute bronchiolitis when compared with 
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